Transgender women on hormone therapy may be at a higher risk for cardiovascular problems, such as stroke, blood clots and heart attack, researchers reported Monday.
The study was done by reviewing eight years of medical records of nearly 5,000 transgender patients in the Kaiser Health system, and looked at patients over the age of 18 who took hormones for gender transition. Over 97,000 cisgender patients — people whose sex assigned at birth matches their gender identity — with similar age and health characteristics were studied for comparison.
The study found that transgender women, who are assigned the male sex at birth, were twice as likely as cisgender men or women to have the blood clot condition venous thromboembolism. Transgender women on hormone therapy were also found to be 80 to 90 percent more likely to have stroke or a heart attack than cisgender women.
link
Study finds health risks for transgender women on hormone therapy
American Buddhist Net 